Radiofrequency Ablation (RFA) in Breast Tumors

  • STATUS
    Recruiting
  • participants needed
    30
  • sponsor
    Hospital Universitari de Bellvitge
Send
Updated on 5 August 2020
See if I qualify
ductal carcinoma
radiofrequency ablation
breast tumor
invasive ductal breast carcinoma

Summary

To validate the efficacy and safety of the cool-tip ablation method for breast tumors smaller than 2 cm.

Description

A prospective, phase II-III study, which will include a series of cases of 30 patients. The hospitals involved will be Bellvitge University Hospital and Hospital del Mar.

Efficacy was evaluated according magnetic resonance image and biopsy of the breast 1 month after the procedure.

Patients will be followed up over a 2-year period to assess cosmetic results, short and long-term complications and possible recurrences.

Details
Condition Breast Cancer Female
Age 65years - 100years
Treatment Cool-tip electrode for Radiofrequency Ablation
Clinical Study IdentifierNCT04389216
SponsorHospital Universitari de Bellvitge
Last Modified on5 August 2020

Eligibility

 Yes No Not Sure

Inclusion Criteria

Infiltrating ductal carcinoma according the biopsy of the breast
Tumor visible by ultrasound, smaller than 2 cm
Located > 1 cm from the chest wall and the skin

Exclusion Criteria

Personal antecedents of breast cancer
Multifocality or intraductal carcinoma
Lobular infiltrating carcinoma
Neoadjuvant therapy
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

ductal carcinoma
radiofrequency ablation
breast tumor
invasive ductal breast carcinoma

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.